Use of Inhaled Epoprostenol in Patients With COVID-19 Receiving Humidified, High-Flow Nasal Oxygen Is Associated With Progressive Respiratory Failure

Keyphrases

• Respiratory Failure 100%
• Inhaled Epoprostenol 100%
• Patients with COVID-19 100%
• High-flow Nasal Oxygen 100%
• Humidified High-flow Nasal Cannula 50%
• Propensity Score Matching 30%
• Hazard Ratio 20%
• Mechanical Ventilation 20%
• COVID-19 20%
• Composite Outcome 20%
• High-flow Nasal Cannula Oxygen 20%
• Treatment Group 10%
• Multivariable 10%
• Kaplan-Meier Curve 10%
• Retrospective Cohort Analysis 10%
• Number of Days 10%
• Multivariable Model 10%
• Clinical Benefit 10%
• Patient Cohort 10%
• Cox Proportional Hazards 10%
• Residual Confounding 10%
• Invasive Mechanical Ventilation 10%
• Multilevel Analysis 10%
• COVID-19 Pneumonia 10%

Medicine and Dentistry

• Respiratory Failure 100%
• Prostacyclin 100%
• COVID-19 100%
• Nasal Cannula 50%
• Artificial Respiration 30%
• Hazard Ratio 20%
• Severe Acute Respiratory Syndrome Coronavirus 2 20%
• Cohort Analysis 10%
• Kaplan Meier Method 10%
• Deterioration 10%
• Propensity Score Matching 10%
• Multilevel Analysis 10%
• Treatment Group 10%
• Primary Outcome 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Respiratory Failure 100%
• Prostacyclin 100%
• SARS Coronavirus 20%
• Deterioration 10%
• Multi-Level Modeling 10%
• Treatment Group 10%